Study of ARC-520 in Patient With Chronic Hepatitis B Virus
NCT02349126
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Stopped
Company decision to pursue alternative clinical trial
Conditions
Chronic Hepatitis B
Interventions
DRUG:
ARC-520 Injection
Sponsor
Arrowhead Pharmaceuticals